secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001606498-24-000069
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical appoints Indrani Franchini to Board of Directors, effective July 1, 2024
--------------------------------------------------------------------------------

- Appointment fills a vacancy; Franchini will serve on Audit and Compliance Committees.
- Compensation includes $70,000 annual cash retainer, $12,500 Audit, $7,500 Compliance, and $190,000 RSU grant.
- Board now comprises 6 directors (5 independent) with 3 women, 2 ethnically diverse.
- Franchini previously EVP/CLO at Alnylam, EVP/CCO at Alexion, and roles at Hess and Pfizer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649824000069/0001606498-24-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649824000069/avns-20240628.htm
  HTML page:      https://secwatch.observer/filing/0001606498-24-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer